Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-18-032211

CBO & EVP gave up 381 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Kassberg Thomas Richard · CBO & EVP

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-21 Shares withheld for taxes : show line 1 in the form −381 $64.79 $24,685 83,460 D
Loading xslF345X03/doc4.xml…